Axogen (AXGN) Research & Development (2010 - 2026)
Axogen's quarterly Research & Development came in at $7.5 million in Q1 2026, up 23.41% year-on-year from $6.1 million in Q1 2025, and down 39.26% quarter-over-quarter from $12.4 million in Q4 2025.
Axogen has reported Research & Development for 17 years, with the latest figure at $7.5 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development rose 23.41% year-over-year to $7.5 million; the trailing twelve-month figure through Mar 2026 stood at $34.3 million (up 29.73% YoY), and the FY2025 full-year result was $32.9 million, up 18.43% from the prior year.
- Research & Development for Q1 2026 stood at $7.5 million, down from $12.4 million in the prior quarter.
- The five-year high for Research & Development was $12.4 million in Q4 2025, with the low at $5.3 million in Q4 2022.
- Average Research & Development over 5 years is $7.1 million, with a median of $7.0 million recorded in 2024.
- Peak annual rise in Research & Development reached 84.61% in 2025, while the deepest fall reached 17.79% in 2025.
- Tracing AXGN's Research & Development over 5 years: stood at $5.3 million in 2022, then surged by 35.89% to $7.2 million in 2023, then fell by 6.56% to $6.7 million in 2024, then jumped by 84.61% to $12.4 million in 2025, then tumbled by 39.26% to $7.5 million in 2026.
- The last three Research & Development figures came in at $7.5 million (Q1 2026), $12.4 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn | 7.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.52 Mn |
| Dec 31, 2025 | 12.38 Mn |
| Sep 30, 2025 | 7.57 Mn |
| Jun 30, 2025 | 6.85 Mn |
| Mar 31, 2025 | 6.09 Mn |
| Dec 31, 2024 | 6.70 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | 6.66 Mn |
| Mar 31, 2024 | 7.41 Mn |
| Dec 31, 2023 | 7.18 Mn |
| Sep 30, 2023 | 6.69 Mn |
| Jun 30, 2023 | 7.14 Mn |
| Mar 31, 2023 | 6.33 Mn |
| Dec 31, 2022 | 5.28 Mn |
| Sep 30, 2022 | 7.05 Mn |
| Jun 30, 2022 | 7.02 Mn |
| Mar 31, 2022 | 6.28 Mn |
| Dec 31, 2021 | 6.30 Mn |
| Sep 30, 2021 | 6.40 Mn |
| Jun 30, 2021 | 5.72 Mn |
| Mar 31, 2021 | 5.75 Mn |
| Dec 31, 2020 | 4.93 Mn |
| Sep 30, 2020 | 4.23 Mn |
| Jun 30, 2020 | 4.07 Mn |
| Mar 31, 2020 | 4.61 Mn |
| Dec 31, 2019 | 4.91 Mn |
| Sep 30, 2019 | 4.18 Mn |
| Jun 30, 2019 | 4.28 Mn |
| Mar 31, 2019 | 4.14 Mn |
| Dec 31, 2018 | 3.81 Mn |
| Sep 30, 2018 | 3.31 Mn |
| Jun 30, 2018 | 2.60 Mn |
| Mar 31, 2018 | 2.06 Mn |
| Dec 31, 2017 | 1.97 Mn |
| Sep 30, 2017 | 1.80 Mn |
| Jun 30, 2017 | 1.52 Mn |
| Mar 31, 2017 | 1.41 Mn |
| Dec 31, 2016 | 1.18 Mn |
| Sep 30, 2016 | 1.12 Mn |
| Jun 30, 2016 | 936,823.00 |
| Mar 31, 2016 | 978,340.00 |
| Dec 31, 2015 | 893,721.00 |
| Sep 30, 2015 | 936,015.00 |
| Jun 30, 2015 | 736,399.00 |
| Mar 31, 2015 | 671,036.00 |
| Dec 31, 2014 | 983,722.00 |
| Sep 30, 2014 | 681,230.00 |
| Jun 30, 2014 | 555,758.00 |
| Mar 31, 2014 | 812,615.00 |
| Dec 31, 2013 | 626,572.00 |
| Sep 30, 2013 | 593,643.00 |
| Jun 30, 2013 | 498,318.00 |
| Mar 31, 2013 | 406,943.00 |
| Dec 31, 2012 | 373,322.00 |
| Sep 30, 2012 | 390,395.00 |
| Jun 30, 2012 | 367,363.00 |
| Mar 31, 2012 | 296,131.00 |
| Dec 31, 2011 | 260,938.00 |
| Sep 30, 2011 | 229,709.00 |
| Jun 30, 2011 | 101,117.00 |
| Mar 31, 2011 | 105,591.00 |
| Dec 31, 2010 | 360,556.00 |
| Sep 30, 2010 | 36,169.00 |